Page 20 - Read Online
P. 20

Xu et al. Plast Aesthet Res 2017;4:116-26                                          Plastic and
           DOI: 10.20517/2347-9264.2017.24
                                                                                  Aesthetic Research

                                                                                               www.parjournal.net
            Topic: Keloid and its Treatment                                                     Open Access


           The radiation therapy in keloids treatment: a
           comprehensive review of pathomechanism,


           damage mechanisms and cellular response



           Jing Xu , Elan Yang , Nan-Ze Yu , You-Bin Wang , Xiao Long
                                                               2
                  1
                                       2
                            2
                                                     2
           1 Peking Union Medical College, Beijing 100730, China.
           2 Department of Plastic Surgery, Peking Union Medical College Hospital, Beijing 100730, China.
           Correspondence to: Dr. Xiao Long, Department of Plastic Surgery, Peking Union Medical College Hospital, Shuaifuyuan 1#, Beijing 100730,
           China. E-mail: pumclongxiao@126.com
           How to cite this article: Xu J, Yang E, Yu NZ, Wang YB, Long X. The radiation therapy in keloids treatment: a comprehensive review of pathomechanism,
           damage mechanisms and cellular response. Plast Aesthet Res 2017;4:116-26.
                           Dr. Xiao Long is associate Professor in Peking Union Medical College Hospital (PUMCH), Division of Plastic and
                           Reconstructive Surgery. She received her doctor’s degree from Peking Union Medical College in 2005. Now she
                           serves as the vice chairman of the Youth Committee of the Chinese Medical Association of Plastic Surgeons. In
                           2015, she was recognized as one of the Top Ten Outstanding Young Doctors by China Youth Daily.






                                         ABSTRACT
            Article history:              Keloid management has always been frustrating and challenging. The combination therapy
            Received: 21-03-2017          of surgical excision and radiation therapy was deemed as the last resort for decades. The
            Accepted: 15-07-2017          authors performed a thorough and comprehensive review over the mechanisms on how
            Published: 28-07-2017         radiation therapy damages  the keloid cells. The keloid cells’ cellular response towards
                                          damage induced by irradiation was also studied based on original and current literatures.
            Key words:                    Mechanisms of damage generated by radiation therapy on keloid cells remained partially
            Radiation therapy,            understood. However, direct damage was identified playing dominant role, in contrast to
            keloids,                      damage involved cancer cell apoptosis. Moreover, the p53 pathway and some inflammatory
            combination therapy           factors like  interleukin-6  were  believed  to  function  in  cellular response  to irradiation.
                                          However, the transforming growth factor beta, which was the major dysregulated pathway
                                          involved in pathogenesis of keloid formation showed no apparent correlation with cellular
                                          response to irradiation damage. These pathways could partially explain radiation resistance
                                          in some refractory keloid lesions. The scientific basis and experimental proof in this field was
                                          still inadequate, which drove us to find more evidence to identify the key regulator response
                                          to damage engendered by radiation therapy. Further pathway identification may benefit the
                                          drug development to prevent keloid recurrence.

                                                                                              Quick Response Code:
                       This is an open access article distributed under the terms of the Creative Commons Attribution-
                       NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work
            non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.


            For reprints contact: service@oaepublish.com

            116                                                                                                                                © 2017 OAE Publishing Inc.  www.oaepublish.com
   15   16   17   18   19   20   21   22   23   24   25